Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Asahi Kasei Corporation Announces Judgment of Lawsuit
Asahi Kasei Corporation announced that a verdict of first hearing was made on the lawsuit, which a subsidiary of Asahi Kasei filed against Actelion Ltd., on November 2008, demanding the payment of damages. As the verdict of the first hearing, Actelion was ordered to pay USD 516.6 million to Asahi Kasei.
Latest Developments for Asahi Kasei Corp
- R&I Affirms Rating on Asahi Kasei Corp at "AA-"; Rating Outlook Stable
- Asahi Kasei Corp Completes Subsequent Offering Period For ZOLL Medical Corp
- Asahi Kasei Corporation Commences Tender Offer For ZOLL Medical Corporation
- Asahi Kasei Corporation To Buy ZOLL Medical Corporation For Up To JPY100 Billion-DJ
Latest Key Developments in Chemicals
- Share this
- Link this
- Digg this
Follow Reuters